Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.62% | $2.00M | €457.92B | 86.92% | 76 Outperform | |
| Royal Bank Of Canada | 1.74% | $1.33M | $230.52B | 48.64% | 75 Outperform | |
| AstraZeneca | 1.66% | $1.27M | $300.81B | 24.33% | 80 Outperform | |
| Novartis AG | 1.65% | $1.26M | CHF230.74B | 30.93% | 80 Outperform | |
| Commonwealth Bank of Australia | 1.64% | $1.25M | AU$288.67B | 19.25% | 64 Neutral | |
| Shell (UK) | 1.60% | $1.22M | £182.70B | 24.58% | 73 Outperform | |
| Siemens | 1.46% | $1.12M | €173.95B | 2.09% | 74 Outperform | |
| Schneider Electric | 1.45% | $1.11M | €144.24B | 13.41% | 62 Neutral | |
| SAP SE | 1.37% | $1.05M | €188.37B | -31.61% | 66 Neutral | |
| Enbridge | 1.33% | $1.01M | C$158.97B | 26.23% | 69 Neutral |